Anton Geerinck - Epidemiology

Author Information

Anton Geerinck is affiliated with the World Health Organization Collaborating Center for Public Health aspects of musculoskeletal health and ageing, Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

Research Contributions

Anton Geerinck has made significant contributions to the field of epidemiology, particularly focusing on musculoskeletal health and ageing. His research includes the development and validation of health-related quality of life questionnaires for sarcopenia, such as the SarQoL® and its short version SF-SarQoL. Additionally, he has investigated the intrinsic capacity and mortality risk in older populations, as well as the transmission of SARS-CoV-2 among primary school children. His work also encompasses studies on magnetic fields and childhood leukemia.

Aliases

Anton Geerinck is also known by the aliases A Geerinck and A. Geerinck.

Publication and Citation Metrics

Metric	Value
Total Papers	43
Total Citations	621
h-index	15

Publications:

Spanish translation, cultural adaptation and validation of the SarQoL®: a specific health-related quality of life questionnaire for sarcopenia

DOI: 10.1186/s12891-022-05125-y

Year: 2022

Exposure to magnetic fields and childhood leukemia: a systematic review and meta-analysis of case-control and cohort studies

DOI: 10.1515/reveh-2021-0112

Year: 2022

Patients’ preferences for quality-of-life aspects in sarcopenia: a best–worst scaling study

DOI: 10.1007/s41999-021-00563-8

Year: 2021

Quality of Life and Sarcopenia

DOI: 10.1002/9781119597896.ch21

Year: 2021

Assessment of the performance of the SarQoL® questionnaire in screening for sarcopenia in older people

DOI: 10.1007/s40520-021-01913-z

Year: 2021

Intrinsic Capacity Defined Using Four Domains and Mortality Risk: A 5-Year Follow-Up of the SarcoPhAge Cohort

DOI: 10.1007/s12603-021-1702-7

Year: 2021

Development and validation of a short version of the Sarcopenia Quality of Life questionnaire: the SF-SarQoL

DOI: 10.1007/s11136-021-02823-3

Year: 2021

Validation of the Hungarian Version of the SarQoL® Questionnaire and Its Association with the SARC-F Screening Tool

DOI: 10.14283/jfa.2021.53

Year: 2021

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL® questionnaire

DOI: 10.1002/jcsm.12687

Year: 2021

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium

DOI: 10.1001/jamanetworkopen.2021.28757

Year: 2021

What Are the Challenges in Managing Diabetes Globally?

How Can Age-Standardization Improve Comparability in Epidemiological Research?

What Are the Health Consequences of Cooking Accidents?

What are Health Authorities?

How Can Statistical Errors Lead to Misleading Conclusions?

What is the International Atomic Energy Agency (IAEA)?

Why Are Long Term Health Benefits Important?

What are Emerging Disease Threats?

What is Aortic Stenosis?

Why is Uterine Surgery Important in Epidemiology?

Partnered Content Networks

Relevant Topics